Latest News for 05/2022
March 2016
-
08 Mar 2016World-leading medicinal chemistry and biology at the Universities of Dundee (Scotland) and Cape Town (South Africa) have been allied to the industrial expertise of the Pharmaceuticals Division of Bayer (Germany), one of the world’s leading pharma companies, in an effort to develop critically needed new treatments for tuberculosis (TB). The collaboration combines some of the world’s best knowledge on TB biology, drug discovery and medicinal chemistry, with access to an industrial library of chemical compounds.
February 2015
-
Drug Discovery Unit and McLean Lab formalise agreement with Pfizer Inc. to research potential new...05 Feb 2015The University of Dundee has entered into a Research Program Agreement with Pfizer Inc. to jointly conduct research that may lead to potential novel treatments for Cystic Fibrosis. The project will be carried out as part of Pfizer’s Rare Disease Consortium and builds on a program of research within the laboratory of Professor Irwin McLean, Head of Molecular Medicine at Dundee, and the University’s Drug Discovery Unit.
March 2013
-
20 Mar 2013The 2013 election of new Fellows of the Royal Society of Edinburgh has seen the honour bestowed on three academics from the College of Life Sciences, University of Dundee. The new Fellows from CLS are:
February 2013
-
13 Feb 2013A major new centre to boost the development of drugs to tackle the foremost diseases of the developing world is to be created at the University of Dundee.
April 2012
-
19 Apr 2012The University of Dundee’s Drug Discovery Unit has been nominated for a prestigious industry award recognising excellence in knowledge exchange.
October 2011
-
27 Oct 2011The University of Dundee has announced a collaboration agreement with TPP Global Development Ltd to establish a drug development fund.
April 2010
-
01 Apr 2010Scientists from the Drug Discovery Unit (DDU) at the University of Dundee – working together with partners at the University of York and the Structural Genomics Consortium - have made a major breakthrough in identifying new treatments for a fatal disease which infects tens of thousands of Africans each year.
